Literature DB >> 16697230

Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis.

Ann-Marie Calander1, Sofie Starckx, Ghislain Opdenakker, Philip Bergin, Marianne Quiding-Järbrink, Andrej Tarkowski.   

Abstract

Matrix metalloproteinases constitute a family of structurally related endopeptidases that are crucial for the normal turnover of the extracellular matrix. Elevated levels of MMP-9 have been demonstrated in synovial fluids of rheumatoid arthritis patients, and a correlation with the severity of the disease has been described. The aim of this study was to explore the impact of MMP-9 expression on joint inflammation and destruction in a model of bacterially induced septic arthritis. MMP-9 knock-out mice and C57Bl6 congenic controls were inoculated intravenously or intra-articularly with Staphylococcus aureus. Arthritis was evaluated clinically and by means of histology. Zymographic analyses were performed to study ex vivo induction of MMP-9 following exposure to S. aureus. The MMP-9 knock-out mice displayed a significantly higher frequency and severity, but not destructivity, of arthritis than did the wild-type mice. The knock-out mice also proved to harbour an increased number of bacteria locally in joints and systemically in kidneys, possibly by impaired extravasation and recruitment of leukocytes and a deficient early defence against infection. Our findings indicate that deficiency in MMP-9 increases the degree of joint inflammation due to decreased bacterial clearance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697230     DOI: 10.1016/j.micinf.2006.01.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  7 in total

1.  CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis.

Authors:  Bikash Sahay; Anju Singh; Arumugam Gnanamani; Rebeca L Patsey; J Edwin Blalock; Timothy J Sellati
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils.

Authors:  Saotomo Itoh; Eri Hamada; Go Kamoshida; Kana Takeshita; Teruaki Oku; Tsutomu Tsuji
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee.

Authors:  Vasileios Christos Fotopoulos; Athina Tzinia; Matthew Tzurbakis; Vasiliki Kalfakakou; Stamatina Levidiotou-Stefanou; Anastasios Georgoulis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-09-24       Impact factor: 4.342

4.  Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi.

Authors:  Andrew J Heilpern; Warren Wertheim; Jia He; George Perides; Roderick T Bronson; Linden T Hu
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

Review 5.  Novel therapeutic interventions towards improved management of septic arthritis.

Authors:  Jian Wang; Liucai Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-06-09       Impact factor: 2.362

6.  Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 & SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition.

Authors:  Kirsten J Koymans; Adinda Bisschop; Mignon M Vughs; Kok P M van Kessel; Carla J C de Haas; Jos A G van Strijp
Journal:  Int J Mol Sci       Date:  2016-07-05       Impact factor: 5.923

7.  Genome-Wide Association Study of Staphylococcus aureus Carriage in a Community-Based Sample of Mexican-Americans in Starr County, Texas.

Authors:  Eric L Brown; Jennifer E Below; Rebecca S B Fischer; Heather T Essigmann; Hao Hu; Chad Huff; D Ashley Robinson; Lauren E Petty; David Aguilar; Graeme I Bell; Craig L Hanis
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.